VBI Vaccines Future Growth
Future criteria checks 2/6
VBI Vaccines is forecast to grow earnings and revenue by 63% and 46.6% per annum respectively while EPS is expected to grow by 73% per annum.
Key information
63.0%
Earnings growth rate
73.0%
EPS growth rate
Biotechs earnings growth | 21.3% |
Revenue growth rate | 46.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook
Sep 22VBI Vaccines gets up to $100M debt funding from K2 HealthVentures
Sep 15Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe
Sep 08VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings
Aug 26VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis
Jun 17Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?
Jun 09Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?
Jan 24VBI Vaccines: Hepatitis Vaccine Approval Can Be A Catalyst For >$1bn Valuation
Oct 31Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?
Oct 06VBI Vaccines: Turning My Focus To VBI-1901
Jul 15VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?
Jul 08Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 59 | -14 | -10 | -4 | 1 |
12/31/2025 | 34 | -25 | -17 | -20 | 1 |
12/31/2024 | 14 | -43 | -37 | -40 | 1 |
12/31/2023 | 9 | -94 | -62 | -61 | N/A |
9/30/2023 | 8 | -115 | -70 | -68 | N/A |
6/30/2023 | 2 | -119 | -81 | -77 | N/A |
3/31/2023 | 1 | -120 | -80 | -75 | N/A |
12/31/2022 | 1 | -113 | -78 | -74 | N/A |
9/30/2022 | 1 | -111 | -77 | -73 | N/A |
6/30/2022 | 1 | -102 | -63 | -60 | N/A |
3/31/2022 | 0 | -73 | -55 | -53 | N/A |
12/31/2021 | 1 | -70 | -42 | -40 | N/A |
9/30/2021 | 1 | -66 | -40 | -38 | N/A |
6/30/2021 | 1 | -63 | -51 | -49 | N/A |
3/31/2021 | 1 | -56 | -47 | -46 | N/A |
12/31/2020 | 1 | -46 | -48 | -47 | N/A |
9/30/2020 | 1 | -42 | -40 | -39 | N/A |
6/30/2020 | 2 | -45 | -39 | -38 | N/A |
3/31/2020 | 2 | -49 | -44 | -42 | N/A |
12/31/2019 | 2 | -55 | -52 | -49 | N/A |
9/30/2019 | 4 | -63 | -54 | -48 | N/A |
6/30/2019 | 4 | -62 | -54 | -47 | N/A |
3/31/2019 | 4 | -66 | -58 | -51 | N/A |
12/31/2018 | 3 | -64 | -52 | -46 | N/A |
9/30/2018 | 1 | -56 | -51 | -47 | N/A |
6/30/2018 | 1 | -50 | -42 | -40 | N/A |
3/31/2018 | 1 | -43 | -33 | -32 | N/A |
12/31/2017 | 1 | -39 | -32 | -31 | N/A |
9/30/2017 | 1 | -36 | N/A | -30 | N/A |
6/30/2017 | 1 | -33 | N/A | -28 | N/A |
3/31/2017 | 1 | -31 | N/A | -25 | N/A |
12/31/2016 | 1 | -23 | N/A | -19 | N/A |
9/30/2016 | 0 | -19 | N/A | -14 | N/A |
6/30/2016 | 0 | -31 | N/A | -14 | N/A |
3/31/2016 | 1 | -25 | N/A | -9 | N/A |
12/31/2015 | 1 | -26 | N/A | -9 | N/A |
9/30/2015 | 2 | -23 | N/A | -8 | N/A |
6/30/2015 | 2 | -6 | N/A | -7 | N/A |
3/31/2015 | 2 | -6 | N/A | -5 | N/A |
12/31/2014 | 3 | -6 | N/A | -5 | N/A |
12/31/2013 | 2 | -9 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VBIV is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VBIV is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VBIV is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VBIV's revenue (46.6% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: VBIV's revenue (46.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VBIV's Return on Equity is forecast to be high in 3 years time